The market for blood plasma: different tissues, same issues - Hallo friendsNOT SOME IMPORTANT INFORMATION, In the article you read this time with the title The market for blood plasma: different tissues, same issues, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article capital markets, Article economy, Article health, Article News, Article politics, Article sports, We write this you can understand. Alright, good read.

Title : The market for blood plasma: different tissues, same issues
link : The market for blood plasma: different tissues, same issues

The market for blood plasma: different tissues, same issues

I'll be speaking at The Plasma Protein Forum, June 12-13 in Washington D.C., on "REPUGNANT TRANSACTIONS AND FORBIDDEN MARKETS: DIFFERENT TISSUES, SAME ISSUES"

Here's the whole program:

DAY ONE:    JUNE 12, 2018

7:00 am–5:30 pm	Registration and Exhibit Hall Open
7:00–8:30 am	Breakfast—Available in Exhibit Halls 1 & 2
8:30–8:45 am	WELCOME & “How Is Your Day?”Jan M. Bult, President & CEO, PPTA
8:45–9:00 am	CHAIRMAN'S MESSAGE David Bell, Chair, PPTA Global Board of Directors; Executive Vice President & General Counsel, Grifols
9:00–10:30 am	PERSPECTIVES: ACCESS TO CARE Moderator:  Larisa Cervenakova, M.D., Ph.D., Medical Director, PPTA
	Speakers:  Tony Castaldo, President, US Hereditary Angioedema AssociationHAE perspective Joanna Chorostowska-Wynimko M.D., Ph.D., D.Sc., Professor, Scientific Director National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland Alpha-1 perspective Professor Paolo Caraceni, Associate Professor, Department of Medical and Surgical Sciences, University of Bologna, Bologna, ItalyANSWER: Long term albumin administration improves survival in patients with decompensated cirrhosis
10:30–11:00 am	BREAK
11:00 am–12:30 pm	CURRENT INDUSTRY AND REGULATORY INITIATIVES IN THE AREAS OF INSPECTIONS AND DONOR HEALTH Moderator:  John Delacourt, Vice President Legal Affairs & Global Operations, PPTA
	Speakers: Ginette Y. Michaud, M.D., Director, Office of Biological Products Operations, U.S. Food & Drug AdministrationFDA’s Office of Biological Products Operations – Form Follows Function Toby L. Simon, M.D., Senior Medical Director, Plasma & Plasma Safety, CSL PlasmaDonor health perspectives: Insights from industry plasma vigilance data and future safety initiatives George B. Schreiber, Sc.D., Director, Epidemiology, PPTA Iron depletion in Source plasma donors; A non sequitur.
12:30–2:00 pm	LUNCH—Buffet Available in Exhibit Halls 1 & 2    Sponsored by:
2:00–4:00 pm	INTERNATIONAL ACCESS TO CARE LANDSCAPE Moderator:  Jan M. Bult, President & CEO, PPTA
	Speakers: P. Martin van Hagen, M.D., Ph.D., Professor, Head, Clinical Immunology Unit Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands Is personalized medicine a national or cross border issue? Dr. Ranjeet S. Ajmani, CEO, PlasmaGen BioSciences Pvt Ltd. Initiatives to improve access to care in India Antonio Condino-Neto, M.D., Ph.D., President, Latin American Society for Immunodeficiencies (LASID)What needs to be done to improve access to Immunoglobulin therapy in Brazil? Diagnosis, Access, Supply
4:00 pm	BREAK – Ice cream social
4:30 pm	Otto Schwarz Award presentation
5:00 pm	REPUGNANT TRANSACTIONS AND FORBIDDEN MARKETS: DIFFERENT TISSUES, SAME ISSUES Alvin E. Roth, Craig and Susan McCaw Professor of Economics, Stanford University; George Gund Professor of Economics and Business Administration, Emeritus, Harvard University; and 2012 recipient of the Nobel Memorial Prize in Economic Sciences
5:45 pm	DAY 1 CLOSING ANNOUNCEMENTS
5:45–7:30 pm	Reception

DAY TWO:    JUNE 13, 2018

7:30 am–1:00 pm	Registration and Exhibit Hall open
7:30–8:30 am	Breakfast—Available in Exhibit Halls 1 & 2
8:30–8:35 am	WELCOME Joshua Penrod, J.D., Ph.D., Vice President, Source & International Affairs, PPTA
8:35–8:50 am	SOURCE DIVISION OUTLOOK Roger Brinser, ‎Chair, PPTA Source Board of Directors; Director, Regulatory, BioLife Plasma Services/Shire
8:50–11:00 am	CURRENT CHALLENGES  Moderator: Joshua Penrod, J.D., Ph.D., Vice President, Source & International Affairs, PPTA
	Speakers: Nicola Lacetera, Ph.D., Associate Professor at the University of Toronto Crowding Out Prof Dr. Liu Zhong, Vice President, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS)Which is safer source plasma for manufacturing in China: apheresis plasma or recovered plasma? Chen Bin, Deputy Director, Medical Safety and Transfusion Division, Department of Medical Regulatory and Management, National Health CommissionThe current situation and challenge of the Chinese plasma management
11:00–11:30 am	BREAK
11:30 am–1:00 pm	CAN COUNTRIES DELIVER ON THEIR OWN? Moderator:  Julia Fabens, Senior Manager International Affairs, PPTA
	Speakers: Bill Bees, Vice President, Plasma Technologies, Prometic Plasma ResourcesCanada–Debunking the Krever Commission Report Peter Jaworski, Ph.D., Professor, Georgetown University, Washington, D.C. Ethics of Compensation Joshua Penrod, J.D., Ph.D., Vice President, Source & International Affairs, PPTAGlobal sufficiency: Obstacles and opportunities

***********
Here are my blog posts on plasma, sorted by date (most recent first), going back to one from 2009.

Thus Article The market for blood plasma: different tissues, same issues

That's an article The market for blood plasma: different tissues, same issues This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article The market for blood plasma: different tissues, same issues with the link address https://notsomeimportant.blogspot.com/2018/06/the-market-for-blood-plasma-different.html

Tweet

Subscribe to receive free email updates: